Abraxane (Celgene), an albumin-particle bound paclitaxel, FDA-approved for advanced non-small cell lung cancer, metastatic breast cancer, and metastatic pancreatic cancer, is actually under investigation also in melanoma patients. This evidence concerns the gene ALB and melanoma.